Therefore, this study in chronic anti-thy1 mesangioproliferative glomerulosclerosis proved that the inhibition of tyrosine kinases signalling through Imatinib directly or indirectly interferes with multiple key pathways to slow the progression of chronic renal disease. This evidence concerns the gene THY1 and glomerulosclerosis.